Oppenheimer & CO Inc Mustang Bio, Inc. Transaction History

Oppenheimer & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.35 - $0.72 $4,233 - $8,708	-12,095 Reduced 11.62%	91,982 $34,000
Q4 2022 Feb 07, 2023	SELL	$0.32 - $0.52 $5,408 - $8,789	-16,903 Reduced 13.97%	104,077 $40,000
Q3 2022 Nov 14, 2022	BUY	$0.46 - $0.76 $34,958 - $57,756	75,996 Added 168.94%	120,980 $57,000
Q4 2021 Feb 02, 2022	SELL	$1.66 - $2.64 $2,662 - $4,234	-1,604 Reduced 3.44%	44,984 $75,000
Q3 2021 Nov 12, 2021	SELL	$2.58 - $3.36 $276,003 - $359,446	-106,978 Reduced 69.66%	46,588 $125,000

Q2 2021 Aug 03, 2021	BUY	$2.7 - $3.81 $345,456 - $487,478	127,947 Added 499.42%	153,566 $510,000
Q1 2021 May 10, 2021	BUY	$3.02 - $5.16 $2,189 - $3,741	725 Added 2.91%	25,619 $85,000
Q4 2020 Feb 11, 2021	BUY	$2.66 - $4.18 $66,218 - $104,056	24,894 New	24,894 $94,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.